David J. Nutt

Death by tricyclic: the real antidepressant scandal?
J Psychopharmacol 2005 19: 123-124. [PDF] [References]  

David J. Nutt

NICE: The National Institute of Clinical Excellence - or Eccentricity? Reflections on the Z-drugs as hypnotics
J Psychopharmacol 2005 19: 125-127. [PDF] [References]  

Chris Alford and Joris Verster

NICE review: not nice for patients!
J Psychopharmacol 2005 19: 129-132. [PDF] [References]  

Ian Anderson

Making decisions in the absence of high quality clinical evidence: we need to bring some science into the judgement
J Psychopharmacol 2005 19: 133. [PDF] [References]  

David Baldwin

Short-term treatment with hypnotic drugs for insomnia: going beyond the evidence
J Psychopharmacol 2005 19: 134-135. [PDF] [References]  

Malcolm Lader

A NICE missed opportunity?
J Psychopharmacol 2005 19: 136-138. [PDF] [References]  

Stella G. Giakoumaki, Eugenia Hourdaki, Vangelis Grinakis, Katerina Theou, and Panos Bitsios

Effects of peripheral sympathetic blockade with dapiprazole on the fear-inhibited light reflex
J Psychopharmacol 2005 19: 139-148. [Abstract] [PDF] [References]  

Kerry A. Waters, Katherine E. Burnham, Desmond O’Connor, Gerard R. Dawson, and Rebecca Dias

Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat
J Psychopharmacol 2005 19: 149-158. [Abstract] [PDF] [References]  

J. Douglas Bremner, Tanja Mletzko, Silke Welter, Sinead Quinn, Chanda Williams, Marijn Brummer, Sajid Siddiq, Lai Reed, Christine M. Heim, and Charles B. Nemeroff

Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study
J Psychopharmacol 2005 19: 159-165. [Abstract] [PDF] [References]  

Bárbara Arias, Rosa Catalán, Cristóbal Gastó, Blanca Gutiérrez, and Lourdes Fañanás

Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
J Psychopharmacol 2005 19: 166-172. [Abstract] [PDF] [References]  

Sarah Elsabagh, David E. Hartley, and Sandra E. File

Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba
J Psychopharmacol 2005 19: 173-181. [Abstract] [PDF] [References]  

David Taylor, Corina Young, Radia Mohamed, Carol Paton, and Rebecca Walwyn

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs
J Psychopharmacol 2005 19: 182-186. [Abstract] [PDF] [References]  

David M. Semple, Andrew M. McIntosh, and Stephen M. Lawrie

Cannabis as a risk factor for psychosis: systematic review
J Psychopharmacol 2005 19: 187-194. [Abstract] [PDF] [References]  

Alejandro Gonzalez and David J. Nutt

Gamma hydroxy butyrate abuse and dependency
J Psychopharmacol 2005 19: 195-204. [Abstract] [PDF] [References]  

Lawrence Scahill, Jennifer Blair, James F. Leckman, and Andrés Martin

Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone
J Psychopharmacol 2005 19: 205-206. [PDF] [References]  

Elizabeth Tovey, Hagen Rampes, and Callum Livingstone

Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice
J Psychopharmacol 2005 19: 207-210. [Abstract] [PDF] [References]  

W. Aichhorn, C. Stuppaeck, and A. B. Whitworth

Risperidone and breast-feeding
J Psychopharmacol 2005 19: 211-213. [Abstract] [PDF] [References]  

Fahad Khalifa Alwahhabi

Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia
J Psychopharmacol 2005 19: 214-216. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.